ReviewBMC pulmonary medicine2025

Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review.

Peng Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.